Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.
about
Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding proteinExpression of hepatoma-derived growth factor family members in the adult central nervous system.Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancerHepatoma-derived growth factor binds DNA through the N-terminal PWWP domainAntibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer.Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected]Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor.Atomic force microscopy characterization of kinase-mediated phosphorylation of a peptide monolayer.The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapyThe isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.Hepatoma-derived growth factor and its role in keloid pathogenesis.Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers.High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.p53 and the PWWP domain containing effector proteins in chromatin damage repair.Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma.Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension.Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis.Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation.The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis.The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells.SUMOylation of the hepatoma-derived growth factor negatively influences its binding to chromatin.Cell surface heparan sulfates mediate internalization of the PWWP/HATH domain of HDGF via macropinocytosis to fine-tune cell signalling processes involved in fibroblast cell migration.Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.Integrating proteomics with electrochemistry for identifying kinase biomarkers.Hepatoma-derived growth factor functions as an unfavorable prognostic marker of human gliomas.The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.The evaluation of hepatoma-derived growth factor in determining of prognosis and estimating of invasive probability of tumoral cells, recurrent, and metastasis of lymphatic glands in breast carcinoma.[Aberrant expression of HDGF and its prognostic values in surgically resected non-small cell lung cancer].Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor.
P2860
Q24320054-2E453686-4E72-4307-883F-1E4ACFD3F471Q25255854-5FF09C4C-5026-4E0B-932E-EBBBB089A9B0Q28383771-F736B00C-7FA4-4900-BC6C-68381D1FAE5FQ33304584-168408BF-9862-4125-AB51-D6BED59250F7Q34106493-79430CF7-7918-4BE6-90A9-3F36F500FD55Q34639683-FB82482A-578C-4BB9-B284-E153FAAFDBB8Q35634321-744B9265-5924-406D-9EC5-6921CA9A224DQ36191446-D8968B55-A432-461E-959A-126C9E157A60Q36828146-EC5E2306-A4F9-4884-8194-C767F36441BDQ36998991-36D38D83-0B3C-4667-8792-9A9428AA3DE7Q37021772-807980CC-3BCD-4B5E-91BC-CF5DA137F4C1Q37310602-E9C1F5A7-896A-4440-A9C1-5E1C2769D828Q37477526-72346F6B-FD80-40F5-8D26-F543D128D326Q37627214-00E85A50-A79D-435C-94A3-D80F3A100B6DQ38066416-875B9DA5-74BF-4508-9684-B0E5DF6B9A7FQ38255171-94F864A3-C4E7-4078-8503-920846CD647AQ38535178-7D6C836B-47D4-47B1-A423-16E05376A9EDQ38859147-3FBA9CD4-E595-4B0A-8D72-8FDF1DA35E1DQ38952715-EBAB0E3B-D912-4A82-ADE3-35ACA46A4270Q39411774-91ED02E5-4215-4E3A-8D38-8D5981ED1023Q39563873-B06EA84E-956B-48C2-B286-6A6D74AB9FB8Q39692289-82433A0B-6C0F-43C0-BB40-4985D0C594A0Q39934743-883B46F9-C4A5-4DFF-AF8D-417F9859F239Q41841187-B060DDFB-9AF0-4BED-8D1D-59CF00359B44Q42015052-0B569CDD-F251-4459-87B9-B2A64BA83176Q42525606-19B2996C-3C55-45A8-A5EF-1FE7A3641573Q42819181-EE70AD94-CE93-4682-82D4-9902C87CDC84Q43521275-1A8797A0-CB7F-451E-A592-60C0390E3346Q45734126-6BB9BB93-3397-4E1B-A3AA-7C354ABC479EQ47165042-EF361683-B43F-421F-BEFA-7F12ABB55C19Q47855178-D8621EC8-F3FC-4584-8108-959139CB18F6Q50903271-BB0F9613-C65E-4571-9B73-B9F7906D49BBQ55263017-39FCB1AC-B75B-4FCF-B072-A33BAFC0DA5BQ55443038-ADE44D09-5B55-499D-B816-BCEDBFD6B036Q55462273-BFB8868A-E16A-406D-B04A-7BB2CAC18C3B
P2860
Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hepatoma-derived growth factor ...... lar endothelial growth factor.
@en
Hepatoma-derived growth factor ...... lar endothelial growth factor.
@nl
type
label
Hepatoma-derived growth factor ...... lar endothelial growth factor.
@en
Hepatoma-derived growth factor ...... lar endothelial growth factor.
@nl
prefLabel
Hepatoma-derived growth factor ...... lar endothelial growth factor.
@en
Hepatoma-derived growth factor ...... lar endothelial growth factor.
@nl
P2093
P2860
P1433
P1476
Hepatoma-derived growth factor ...... lar endothelial growth factor.
@en
P2093
Allen D Everett
Hideji Nakamura
Hirayuki Enomoto
Hiroaki Ito
Hirokazu Uyama
Ichiro Kawase
Kenya Yoshida
Masanobu Funamoto
Tomonori Hirotani
Toshikazu Hada
P2860
P304
P356
10.1111/J.1349-7006.2003.TB01397.X
P577
2003-12-01T00:00:00Z